Wall Street’s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Merck & Co Inc (NYSE:MRK)

• Dividend Yield: 2.95%
• Wells Fargo analyst Mohit Bansal maintained an Overweight rating and raised the price target from $135 to $150 on March 12, 2026. This analyst has an accuracy rate of 69%.
• RBC Capital analyst Trung Huynh initiated coverage on the stock with an Outperform rating and a price target of $142 on Feb. 25, 2026. This analyst has an accuracy rate of 72%
• Recent News: On March 16, Merck highlighted new …

Full story available on Benzinga.com